SUBSCRIBE
SUBSCRIBE
News   FDA

Vacci-Test Corporation Release: European Approval of VACCI-TEST(TM) Tetanus

June 10, 2008 | 
1 min read
CALGARY, ALBERTA--(Marketwire - June 10, 2008) - Vacci-Test Corporation ("VTC") of Calgary, Alberta, Canada is pleased to announce that its subsidiary, Vacci-Test Europe, has received the CE mark for its first product, VACCI-TEST™ Tetanus.
FDA Approvals
MORE ON THIS TOPIC
Crisis. Sanctions. Withdrawal of investment and capital. Stop participation. The collapse of the company, the split of business partners.
Autoimmune disease
Intercept Withdraws Embattled Liver Drug from US Market
September 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Unpacking the Latest MAHA Report, RFK’s Senate Appearance, FDA’s CRL Drop and More
September 10, 2025
 · 
1 min read
 · 
Jef Akst
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Complete response letters
FDA Turns Away Ultra-Rare Disease Therapy
September 9, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA recently approved BESREMi for the treatment of
Manufacturing
As Ori Wins Designation, FDA’s Advanced Manufacturing Program Nears Proof Point
September 9, 2025
 · 
5 min read
 · 
Nick Paul Taylor